Pfizer-BioNTech COVID-19 vaccine receives WHO validation

AFP

The Pfizer-BioNTech COVID-19 vaccine became the first vaccine to receive the World Health Organisation (WHO) validation for emergency use since the pandemic outbreak.

“Regulatory experts from around the world reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy and quality. They found that the vaccine met the must-have criteria for safety, efficacy and that the benefits of using it to address the disease offset potential risks,” WHO Tweeted.

More from International news

News